InsiderFlow

HEPA

HEPION PHARMS INC+0.00 ()
Prev Close·MCap$465,975·P/E·Vol·Yield

Buys (12M)

4

$400.0K

Sells (12M)

0

$0.00

Net Activity

Net Buyer

$400.0K

Active Insiders

4

last 12 mo

Over the past 12 months, insider activity at HEPION PHARMS INC (HEPA) has been exclusively buying, with 4 insider purchases totaling $400.0K and 0 insider sales totaling $0.00. The most recent insider transaction was by Appajosyula Sireesh (director), who purchased $50.0K worth of shares on Apr 27, 2026. HEPION PHARMS INC operates in the Technology sector, within the General industry, with a market cap of $465,975.

HEPA Insider Trading Activity

DateInsiderTypeValue
Apr 27, 2026 Appajosyula SireeshBuy$50.0K
Apr 27, 2026 LoPriore Vincent SBuy$250.0K
Apr 27, 2026 Purcell Michael J.Buy$50.0K
Apr 27, 2026 Stetz Gary S.Buy$50.0K

HEPA Insider Buying Activity

The following table shows recent insider purchases of HEPION PHARMS INC (HEPA) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Apr 27, 2026 Appajosyula SireeshBuy$50.0K
Apr 27, 2026 LoPriore Vincent SBuy$250.0K
Apr 27, 2026 Purcell Michael J.Buy$50.0K
Apr 27, 2026 Stetz Gary S.Buy$50.0K

HEPA Insider Selling Activity

The following table shows recent insider sales of HEPION PHARMS INC (HEPA) stock reported via SEC Form 4 filings.

No insider selling activity found for HEPA in the last 12 months.

HEPA Insiders

Appajosyula Sireesh

director

Bought $50.0K
1 tradesLast: Apr 27, 2026
Purcell Michael J.

director

Bought $50.0K
1 tradesLast: Apr 27, 2026
LoPriore Vincent S

director, 10 percent owner, officer: Executive Chairman

Bought $250.0K
1 tradesLast: Apr 27, 2026
Stetz Gary S.

director, officer: Interim CEO

Bought $50.0K
1 tradesLast: Apr 27, 2026